S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AQST Aquestive Therapeutics Inc

5.09

0.00 (0.00%)

Pre Market

Last Updated: 03:00:20

Delayed by 15 minutes

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Aquestive Therapeutics Charts.

Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Aquestive Therapeutics Charts.

Aquestive Therapeutics Inc News

Form 8-K - Current report
Monday 9 September 2024 (2 weeks ago) • Edgar (US Regulatory)

Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th
Monday 9 September 2024 (2 weeks ago) • GlobeNewswire Inc.

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
Thursday 22 August 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 14 August 2024 (1 month ago) • Edgar (US Regulatory)

Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™
Wednesday 14 August 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 12 August 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)

Aquestive Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Tuesday 6 August 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 25 July 2024 (2 months ago) • Edgar (US Regulatory)

Aquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study
Thursday 25 July 2024 (2 months ago) • GlobeNewswire Inc.

Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET
Tuesday 23 July 2024 (2 months ago) • GlobeNewswire Inc.

More Aquestive Therapeutics Inc News Articles

Invesco Focused Discover...

Bnp Paribas Easy Equity ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions